In the 1980s, approximately 80% of active pharmaceutical ingredients (APIs) for products consumed in the European Union were produced within its borders. Today, this proportion has dwindled to less than 20%, with over 45% of APIs by volume coming from China.(1) Unprecedented recent shortages in generic drugs and fine chemicals...
Meyer Hans-Peter
—
July 2024
— 471
views